9-Cis-retinoic acid reduces ischemic brain injury in rodents via bone morphogenetic protein

Journal of Neuroscience Research

Volumn 87, Issue 2, 2009, Pages 545-555

  Shen, Hui ^a   Luo, Yu ^a   Kuo, Chi Chung ^a   Deng, Xiaolin ^a   Fang, Chen Fu ^a   Harvey, Brandon K ^a   Hoffer, Barry J ^a   Wang, Yun ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

BMP7; Neuroprotection; Retinoic acid; Stroke

Indexed keywords

ALITRETINOIN; NOGGIN; OSTEOGENIC PROTEIN 1; RETINOIC ACID; CARRIER PROTEIN; MESSENGER RNA; NEUROPROTECTIVE AGENT; NOGGIN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE EXPRESSION; LOCOMOTION; MALE; MIDDLE CEREBRAL ARTERY; NEUROLOGIC DISEASE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RODENT; ANIMAL; BIOSYNTHESIS; CEREBRAL ARTERY DISEASE; CONVALESCENCE; DRUG EFFECT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MOTOR ACTIVITY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; BRAIN ISCHEMIA; CARRIER PROTEINS; GENE EXPRESSION; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRETINOIN;

EID: 62849100008     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21865     Document Type: Article

References (43)

1. Ahlemeyer B, Huhne R, Krieglstein J. 2000. Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression. J Neurosci Res 60:767-778.
2. Ahlemeyer B, Bauerbach E, Plath M, Steuber M, Heers C, Tegtmeier F, Kriegistein J. 2001. Retinoic acid reduces apoptosis and oxidative stress by preservation of SOD protein level. Free Radic Biol Med 30:1067-1077.
3. Allenby G, Janocha. R, Kazmer S, Speck J, Grippo JF, Levin AA. 1994. Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors alpha, beta, and gamma. Retinoic acid receptor gamma binds all-trans-retinoic acid preferentially over 9-cis-retinoic acid. J Biol Chem 269:16689-16695.
4. Bederson JB, Pitts LK, Tsuji M, Nishimura MC, Davis RL; Bartkowski H. 1986. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-476.
5. Blondeau N, Widmann C, Lazdunski M, Heurteaux C. 2002. Polyunsaturated fatty acids induce ischemic and epileptic tolerance 5. Neuroscience 109:231-241.
6. Boniece IR, Wagner JA. 1995. NGF protects PC12 cells against ischemia by a mechanism that requires the N-kinase. J Neurosci Res 40:1-9.
7. Borlongan CV, Hida H. 1998. Early assessment of motor dysfunctions aids in successful occlusion of the middle cerebral artery. Neuroreport 9:3615-3621.
8. Chang CF, Morales M, Chou J, Chen HL, Hoffer BJ, Wang Y. 2002. Bone morphogenetic proteins are involved in fetal kidney tissue transplantation-induced neuroprotection in stroke rats. Neuropharmacology 43:418-426.
9. Chang CF, Lin SZ, Chiang YH, Morales M, Chou J, Lein P, Chen HL, Hoffer BJ, Wang Y. 2003. Intravenous admininstration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke 34:558-564.
10. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. 1986. A model of focal ischemic stroke in the rat: reproducible extensive cortical in farction. Stroke 17:738-743.
11. Chou J, Harvey BK, Ebendal T, Hoffer BJ, Wang Y. 2008a. Nigrostriatal alterations in bone morphogenetic protein receptor II dominant negative mice. Acta Neurochir Suppl 101:93-98.
12. Chou J, Lu Y, Kuo CC, Powers K, Shen H, Harvey BK, Hoffer BJ, Wang Y. 2008b. Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents. Neuroscience 151:92-103.
13. Cox S, Harvey BK, Sanchez JF, Wang JY, Wang Y. 2004. Mediation of BMP7 neuroprotection by MAPK and PKC in rat primary cortical cultures. Brain Res 1010:55-61.
14. de Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T. 2000. Docosahexaenoic acid a ligand for the retinoid X receptor in mouse brain. Science 290:2140-2144.
15. Deng X, Ladenheim B, Tsao LI, Cadet JL. 1999. Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J Neurosci 19:10107-10115.
16. Dupe V, Ghyselinck NB, Thomazy V, Nagy L, Davies PJ, Chambon P, Mark M. 1999. Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. Dev Biol 208:30-43.
17. Glozman S, Green P, Yavin E. 1998. Intraamniotic ethyl docosahexaenoate administration protects fetal rat brain from ischemic stress. J Neurochem 70:2484-2491.
18. Goldstein JT, Dobrzyn A, Clagett-Dame M, Pike JW, DeLuca HF. 2003. Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor 1. Arch Biochem Biophys 420:185-193.
19. Harvey BK, Mark A, Chou J, Chen GJ, Hoffer BJ, Wang Y. 2004a. Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease. Brain Res 1022:88-95.
20. Harvey BK, Shen H, Chen GJ, Yoshida Y, Wang Y. 2004b. Midkine and retinoic acid reduce cerebral infarction induced by middle cerebral artery ligation in rats. Neurosci Lett 369:138-141.
21. Herget T, Specht H, Esdar C, Oehrlein SA, Maelicke A. 1998. Retinoic acid induces apoptosis-associated neural differentiation of a murine teratocarcinoma cell line. J Neurochem 70:47-58.
22. Heurteaux C, Laigle C, Blondeau N, Jarretou G, Lazdunski M. 2006. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia 4. Neuroscience 137:241-251.
23. Horton C, Maden M. 1995. Endogenous distribution of retinoids during normal development and teratogenesis in the mouse embryo. Dev Dyn 202:312-323.
24. Kitamura M, Ishikawa Y, Moreno-Manzano V, Xu Q, Konta T, Lucio-Cazana J, Furusu A, Nakayama K. 2002. Intervention by retinoic acid in oxidative stress-induced apoptosis. Nephrol Dial Transplant 17(Suppl 9):84-87.
25. Kraft JC, Schuh T, Juchau M, Kimelman D. 1994. The retinoid X receptor ligand, 9-cis-retinoic acid, is a potential regulator of early Xenopus development. Proc Natl Acad Sci U S A 91:3067-3071.
26. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A. 1992. 9-Cis., retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature 355:359-361.
27. Lin SZ, Hoffer BJ, Kaplan P, Wang Y. 1999. Osteogenic protein-1 protects against cerebral infarction induced by MCA-ligation in adult rats. Stroke 30:126-133.
28. Maden M, Hind M. 2003. Retinoic acid, a regeneration-inducing molecule. Dev Dyn 226:237-244.
29. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. 1990. Nuclear receptor that identifies a novel retinoic acid response pathway. Nattre 345:224-229.
30. McCaffery PJ, Adams J, Maden M, Rosa-Molinar E. 2003. Too much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen. Eur J Neurosci 18:457-472.
31. Mic FA, Molotkov A, Benbrook DM, Duester G. 2003. Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synth6is. Proc Natl Acad Sci U SA 100:7135-7140.
32. Paralkar VM, Grasser WA, Mansolf AL,.,Baumann AP, Owen TA, Smock SL, Martinovic S, Borovecki F, Vukicevic S,Ke HZ, Thompson DD. 2002. Regulation of BMP-7 expression by retinoic acid and prostaglandin E2. J Cell Physiol 190:207-217.
33. Perides G, Jensen FE, Edgecomb P, Rueger DC, Charness ME. 1995. Neuroprotective effect of human osteogenic protein-1 in a rat model of cerebral hypoxia/ischemia. Neurosci Lett 187:21-24
34. Raghavendra R, Vowen KK, Dhodda. VK, Song G, Franklin JL, Gavva NR, Dempsey RJ. 2002. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J Neurochem 83:1072-1086.
35. Shinozaki Y, Sato Y, Koizumi S, Ohno Y, Nagao, T, Inoue K. 2007. Retinoic acids acting through retinoid receptors protect hippocampal neurons from oxygen-glucose deprivation-mediated cell death by inhibition of c-jun-N-terminal kinase and p38 mitogen-activated protein kinase 1. Neuroscience 147:153-163.
36. Tsai MJ, Weng CF, Shyue SK, Liou DY, Chen CH, Chiu CW, Yang TH, Pan HA, Liao RI, Kuo HS, Huang MC, Huang WC, Hoffer BJ, Cheng H. 2007. Dual effect of adenovirus-mediated trarisfer of BMP7 in mixed neuron-glial cultures; neuroprotection and cellular differentiation: J Neurosci Res 85:2950-2959.
37. Ulven SM, Gundersen TE, Sakhi AK, Glover JC, Blomhoff R. 2001. Quantitative axial profiles of retinoic acid in the embryonic mouse spinal cord: 9-cis retinoic acid only detected after all-trans-retinoic acid levels are super-elevated experimentally. Dev Dyn 222:341-353.
38. Umemura K, Toshima Y, Asai F, Nakashima M. 1995. Effect of dietary docosahexaenoic acid in the rat middle cerebral artery thrombosis model. Thromb Res 78:379-397.
39. Wang Y, Chang CF, Morales M, Chou J, Chen HL, Chiang YH, Lin SZ, Cadet J, Deng X, Wang JY, Chen SY, Kaplan PL, Hoffer BJ. 2001. Bone morphorgenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke 32:2170-2178.
40. Wang Y, Chang CF, Morales M, Chiang YH, Harvey BK, Su TP, Tsao LI, Chen SY, Thiemermann C. 2003. Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain. J Neurosci 23:7958-7965.
41. Werner EA, Deluca HF. 2001. Metabolism of a physiological amount of all-trans-retinol in the vitamin A-deficient rat. Arch Biochem Biophys 393:262-270.
42. Zhelyaznik N, Schrage K, McCaffery P, Mey J. 2003. Activation of retinoic acid signalling after sciatic nerve injury: up-regulation of cellular retinoid binding proteins. Eur J Neurosci 18:1033-1040.
43. Zheng A, Savolainen ER, Koistinen P. 1997. All-trans retinoic acid induces apoptosis in acute myeloblastic leukaemia cells. Apoptosis 2: 319-329.